Outcomes4Me Inc., the developer of the leading, direct-to-patient, AI-driven platform transforming the cancer-care experience, announced that its German affiliate Outcomes4Me Germany GmbH has acquired...
Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, and Databricks, the Data and AI company, announced...
ValGenesis, Inc., the global innovator in digital validation lifecycle management, announced the launch of ValGenesis Smart GxP™, the first AI-enabled platform purpose-built to unify...
Tevogen, provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™.
Tevogen.AI™ aims to integrate advanced machine learning and predictive modeling into Tevogen...
The initiative will apply its massive, multimodal dataset to build models that aim to improve diagnostic, prognostic, and predictive modeling
Tempus AI, Inc., a technology...
Vaniam Group™, a leader in medical communications, is proud to announce the launch of Vaniam Intelligence™, our platform that integrates proprietary artificial intelligence (AI)...
Transcripta Bio announced a research collaboration with Microsoft Research to accelerate the discovery of disease-gene associations using advanced artificial intelligence (AI) and large-scale transcriptomic...
Strategic Collaboration Between Ontada and Trinity Leverages Advanced Analytics and Community Oncology Insights to Improve Provider Outreach and Patient Care
Trinity Life Sciences, a leader...